89bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
89bio, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $16.36 per share as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2021-11-12
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $16.36.
- 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $16.25.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $15.61.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $12.79.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2021-09-30 | $16.36 10-Q · filed 2021-11-12 |
| 2021-06-30 | $16.25 10-Q · filed 2021-08-13 |
| 2021-03-31 | $15.61 10-Q · filed 2021-05-14 |
| 2020-12-31 | $12.79 10-Q · filed 2021-11-12 |
| 2020-09-30 | $12.08 10-Q · filed 2020-11-13 |
| 2020-06-30 | $11.44 10-Q · filed 2020-08-13 |
| 2020-03-31 | $10.62 10-Q · filed 2020-05-13 |
| 2019-12-31 | $3.34 10-Q · filed 2020-11-13 |